AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $31,000 | -18.4% | 65,597 | -2.4% | 0.00% | – |
Q4 2021 | $38,000 | -79.7% | 67,221 | -40.1% | 0.00% | – |
Q3 2021 | $187,000 | +34.5% | 112,146 | +34.4% | 0.00% | – |
Q2 2021 | $139,000 | +826.7% | 83,427 | +126.7% | 0.00% | – |
Q4 2018 | $15,000 | -21.1% | 36,793 | +0.5% | 0.00% | – |
Q3 2018 | $19,000 | -69.4% | 36,597 | +29.7% | 0.00% | – |
Q2 2018 | $62,000 | -95.5% | 28,211 | -84.6% | 0.00% | -100.0% |
Q1 2015 | $1,376,000 | – | 182,755 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
NTB Financial Corp | 146,100 | $83,000 | 0.06% |
Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |